Cargando…
Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
BACKGROUND: The pathophysiology of chemotherapy-induced peripheral neuropathy (CIPN) is not well understood. Currently, dose reduction is the only recommendation for alleviating symptoms, often leading to premature treatment cessation. The primary aim of this analysis was to determine the associatio...
Autores principales: | Mongiovi, Jennifer M., Zirpoli, Gary R., Cannioto, Rikki, Sucheston-Campbell, Lara E., Hershman, Dawn L., Unger, Joseph M., Moore, Halle C. F., Stewart, James A., Isaacs, Claudine, Hobday, Timothy J., Salim, Muhammad, Hortobagyi, Gabriel N., Gralow, Julie R., Thomas Budd, G., Albain, Kathy S., Ambrosone, Christine B., McCann, Susan E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264595/ https://www.ncbi.nlm.nih.gov/pubmed/30486865 http://dx.doi.org/10.1186/s13058-018-1077-9 |
Ejemplares similares
-
Supplement use during an intergroup clinical trial for breast cancer (S0221)
por: Zirpoli, Gary R., et al.
Publicado: (2013) -
Germline genetic variants in ABCB1, ABCC1, and ALDH1A1 and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer
por: Yao, Song, et al.
Publicado: (2013) -
Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221
por: Chen, Ciao-Sin, et al.
Publicado: (2023) -
Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer
por: Cannioto, Rikki A., et al.
Publicado: (2023) -
How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
por: Crew, Katherine D., et al.
Publicado: (2017)